Posted
June 28 - Healthcare economist Paul Keckley says the upholding of President Obama's healthcare reform bill might mean biotech companies will be less likely to invest in research and development.
02:56
02:11
01:15
02:09
02:15
02:07
01:47
02:08
02:59
01:05
01:23
03:11
03:39
00:41
00:39
02:30
01:16
01:41
00:58
02:00
00:41
01:08
01:35
01:09
00:40
01:33
01:21
01:09
00:26
01:54
01:30
01:43
02:44
01:16
00:35
01:08
02:25
01:16
01:19
01:58
01:12
00:35
01:48
02:57
01:36
02:00
01:25
02:44
00:48
01:18
00:45
02:49
02:16